Category: Biotech
-
![Revive Therapeutics (RVV.C): Covid came, Covid went, but Revive is still fighting]()
Revive Therapeutics (RVV.C): Covid came, Covid went, but Revive is still fighting
Back at the dawn of Covid-19, a load of public companies started pumping out news releases that claimed they were going to be entering the medical space. In the best tradition of Howe Street, long dormant mining companies suddenly became med-tech deals, hawking everything from clear plastic checkout counter dividers to virus sniffing doorways to…
-
![Core Story: FendX Technologies (FNDX.C) repels and kills pathogens and viruses]()
Core Story: FendX Technologies (FNDX.C) repels and kills pathogens and viruses
We went after this company as a client because there are three things about it that make me swoon. 1: The CEO has done it all before, in this industry, and has more knowledge about her domain than most 2: The product is needed, necessary, cutting edge, and quickly developing with their academic partners 3:…
-
![Multi-Company Wrap: Watching the watchlist so you don’t have to]()
Multi-Company Wrap: Watching the watchlist so you don’t have to
We have some 29 companies on our watchlist, all in a variety of sectors, that we’re covering at any one time. Some are clients, some not, some are on deaths door, some are skyrocketing, so we’ve decided to wrap them all up into one monthly wrap so you can keep track of everything at once.…
-
![Pubco cocaine is here: What does it mean, who’s in, and who’s real?]()
Pubco cocaine is here: What does it mean, who’s in, and who’s real?
I recently listened to a podcast episode of Search Engine with PJ Vogt, and I REALLY got into it. The episode was titled, “Why are drug dealers putting fentanyl in everything?” I’d asked myself the same question many times – why kill your customers? I’d recommend you go listen because the answer is a lot…
-
![Medexus Pharmaceuticals (MDP.TO) Q2 2023 revenue expected to exceed US$27 million]()
Medexus Pharmaceuticals (MDP.TO) Q2 2023 revenue expected to exceed US$27 million
Medexus Pharmaceuticals (MDP.TO) is a specialty pharma company that has been making big moves on the charts. The company is not a biotech company. They do not do research and development, but instead bring over drugs that are already licensed in Western Europe to North America which sees them carve out a nice and profitable…
-
![Three biotech stocks you may have missed]()
Three biotech stocks you may have missed
Kezar Life Sciences Inc. Between 2020 and 2021, year-over-year (YoY) funding in the biotech market increased by an impressive 39.6%. Currently, some of the biggest trends in this market include personalized medicine, drug research, artificial intelligence, big data, and synthetic biology. In total, the biotech market is expected to increase from USD$852.88 billion in 2020,…
-
![Revive Therapeutics (RVV.C) clears FDA hurdles]()
Revive Therapeutics (RVV.C) clears FDA hurdles
Last year Big Pharma unleashed 1,500 lobbyists to Washington, DC, who then cut cheques for $177 million to keep drug costs high. The lobbyists deserve bonuses. The average U.S. citizen spends $1,200 per year on prescription medicines, while people in other western countries spend an average of $550/year. Public health data indicates that the gluttony…
-
![To Invest or Not: Bionano Genomics (BNGO.Q)]()
To Invest or Not: Bionano Genomics (BNGO.Q)
In this episode, we look at a life sciences instrumentation company in the genome analysis space called Bionano Genomics (BNGO.Q). The company develops and markets the Saphyr system, a platform used for ultra-sensitive and ultra-specific structural variation detection. This Optical Genome Mapping (OGM) platform can detect these large Structural Variations responsible for genetic diseases and…
-
![Today’s Idea: Revive Therapeutics (RVV.C) offers treatments for a mixed-bag of diseases, but the upside is all yours]()
Today’s Idea: Revive Therapeutics (RVV.C) offers treatments for a mixed-bag of diseases, but the upside is all yours
We’re closing in on three years now and it’s becoming hard to believe there was a market before COVID-19. We can barely remember it. Cannabis was a thing briefly, and before that we had crypto, and after cannabis’ untimely deflation in the summer of 2018, we were looking for the next source of market exuberance.…
-
![Graphene Manufacturing Group (GMG.V) produces laboratory-grade graphene from methane gas]()
Graphene Manufacturing Group (GMG.V) produces laboratory-grade graphene from methane gas
Eight years ago, Physics World published an article announcing that graphene was a “miracle substance” so strong that a sheet of graphene the thickness of “Clingfilm” could support the weight of an elephant. “Graphene is a layer of carbon just one atom thick and since it was first isolated in 2004 its remarkable electronic and…
